Ingersoll Rand reported adjusted earnings of $0.86 per share, topping the $0.85 consensus, while revenue rose 9% to $2.049 billion and orders increased 5% to $2.043 million. The beat underscores resilient demand and reinforces the company’s growth outlook, supporting its $33 billion market cap and recent share rally.

Key Highlights

  • Adjusted EPS $0.86 topped the $0.85 consensus, marking a 7% rise from the prior year.
  • Revenue climbed 9% year‑over‑year to $2.049 billion, with orders up 5% to $2,043 million.
  • Adjusted EBITDA grew 2% to $520 million, delivering a 25.4% margin.
  • Free cash flow reached $269 million, while liquidity stood at $3.8 billion.

Ingersoll Rand (NYSE: IR) reported an adjusted earnings per share of $0.86 for the quarter ended June 30, beating the $0.85 consensus estimate. Revenue rose 9% to $2.049 billion, and orders increased 5% to $2,043 million, reflecting solid demand across its portfolio. Share activity was modest, with only minor intra‑day movement.

Quarterly Beat Highlights

The adjusted EPS of $0.86 exceeded analyst expectations of $0.85, delivering a meaningful 7% increase versus the comparable quarter last year. Orders of $2,043 million supported a 9% revenue expansion to $2,049 million. Adjusted net income reached $339 million, translating to $0.86 per share, while GAAP net income was $257 million ($0.66 per share).

These results reinforce the company's execution narrative and underscore its “execution excellence” strategy. The stronger top line suggests the firm can maintain growth momentum despite ongoing macro‑economic headwinds.

Segment Performance

The Industrial Technologies & Services (IT&S) segment recorded orders of $1,621 million, up 4%, and revenues of $1,622 million, up 9% year‑over‑year, delivering adjusted EBITDA of $435 million, a 2% increase, with the margin easing to 26.8%. In contrast, the Precision & Science Technologies (P&ST) segment posted orders rising 11% to $422 million and revenues climbing 8% to $427 million, while adjusted EBITDA surged 15% to $135 million and the margin expanded to 31.5%. This split performance highlights where growth momentum is strongest, with life‑science and precision technologies outpacing the more cyclical compressor market, indicating that diversification is beginning to offset regional market softness.

Balance Sheet and Cash Flow Strength

Liquidity stands at $3.8 billion, comprising $1.2 billion in cash and $2.6 billion of undrawn credit facilities, providing a strong financial cushion. Operating cash flow generated $296 million, resulting in free cash flow of $269 million for the quarter. Net debt to adjusted EBITDA leverage remained steady at 1.7x, reflecting disciplined capital management.

Moody’s upgraded the credit rating to Baa1, confirming an investment‑grade status and reducing funding costs. The market’s response reflects confidence in the firm’s cash‑generation capacity as a buffer against potential economic volatility.

Outlook and Upcoming Catalysts

Management reaffirmed full‑year guidance, targeting revenue growth of 4% to 6.5% and adjusted EBITDA between $2,130 million and $2,190 million, with adjusted EPS projected at $3.45‑$3.57, near the top of the range. The company also announced the signing of an acquisition of Fai Filtri s.r.l. Slated to close in Q4 2026, and a pending acquisition of a U.S. blower maker expected to finalize on July 31.

Investors will closely monitor the earnings conference call scheduled for July 31 at 8:00 a.m. ET for further insight on the acquisitions and the company’s ability to meet its high‑end EPS target. The outcome of these deals will determine whether the firm can sustain its momentum and deliver on the optimistic outlook.

Peers Moving on This News

  • Parker-Hannifin Corp (PH) little changed
  • Illinois Tool Works Inc (ITW) little changed
  • Dover Corp (DOV) little changed

Analysis based on the Form 8-K filed 30 July 2026; figures verified against the filing and live market data.

This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.